EPRX — Eupraxia Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Eupraxia Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23.7	18.3	19.3	33.1	80.6
Net Total Receivables	0.34	0.09	0.191	0.229	0.674
Prepaid Expenses
Total Current Assets	24.2	18.6	19.8	34.4	85.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.466	0.531	0.456	0.425	0.987
Other Long Term Assets
Total Assets	24.7	19.1	20.3	34.9	86.2
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.79	3.06	19.4	3.1	5.63
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	8.58	11.3	18.1	1.54	4.11
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.1	7.79	2.22	33.4	82
Total Liabilities & Shareholders' Equity	24.7	19.1	20.3	34.9	86.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding